Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-565-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- July 2010
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Version / remarks:
- March 2003
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- July 2012
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 2-acetyl-3-(4-hexadecoxyphenyl)-1,4-benzoquinone
- EC Number:
- 947-565-8
- Molecular formula:
- C30 H42 O4
- IUPAC Name:
- 2-acetyl-3-(4-hexadecoxyphenyl)-1,4-benzoquinone
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA:J
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Janvier, Le Genest-Saint-Isle, France
- Females (if applicable) nulliparous and non-pregnant: yes
- Microbiological status of animals, when known: unknown
- Age at study initiation: approximately 10 weeks old
- Weight at study initiation: 19.0 to 23.5 g
- Housing:
On arrival and following assignment to the study, animals were group housed (up to 5 animals of the same sex and same dosing group together) in polycarbonate cages (Makrolon MIII type; height 18 cm.) containing sterilized sawdust as bedding material (Lignocel S 8-15, JRS - J.Rettenmaier & Söhne GmbH + CO. KG, Rosenberg, Germany) equipped with water bottles. The rooms in which the animals were kept were documented in the study records.
Animals were separated during designated procedures/activities. Each cage was clearly labeled.
- Diet (e.g. ad libitum):
Pelleted rodent diet (SM R/M-Z from SSNIFF® Spezialdiäten GmbH, Soest, Germany) was provided ad libitum throughout the study, except during designated procedures.
The feed was analyzed by the supplier for nutritional components and environmental contaminants. Results of the analysis were provided by the supplier and are on file at the Test Facility.
It is considered that there were no known contaminants in the feed that would interfere with the objectives of the study.
- Water (e.g. ad libitum):
Municipal tap-water was freely available to each animal via water bottles.
Periodic analysis of the water was performed, and results of these analyses are on file at the Test Facility.
It is considered that there were no known contaminants in the water that would interfere with the objectives of the study.
- Acclimation period:
The animals were allowed to acclimate to the Test Facility toxicology accommodation for at least 5 days before the commencement of dosing.
- Indication of any skin lesions:
Before the initiation of dosing, a health inspection was performed and any assigned animal considered unsuitable for use in the study were replaced by alternate animals obtained from the same shipment and maintained under the same environmental conditions.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22°C
- Humidity (%): 42 to 61%.
- Air changes (per hr): 10 or more
- Photoperiod (hrs dark / hrs light): 12 hour light/12 hour dark cycle
- IN-LIFE DATES: From: 16 Oct 2018 To: 19 Nov 2018
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- test item concentrations 1, 2 and 5%
- No. of animals per dose:
- 5
- Details on study design:
- PRE-SCREEN TESTS:
- Compound solubility:
The vehicle was chosen from the vehicles specified in the test guideline (in order of preference): Acetone/Olive oil (4:1 v/v), N,N-dimethylformamide, methylethylketone, propylene glycol, dimethylsulfoxide and 1% Pluronic© L92 in Elix water (in case an aqueous vehicle is suitable). The vehicle was selected on the basis of maximizing the solubility based on trial preparations performed at Charles River Den Bosch and on information provided by the Sponsor. Trial preparations were performed to select the suitable vehicle and to establish a suitable formulation procedure.
- Irritation: /
- Systemic toxicity:
At a 10%, 25% and 50% test item concentration, clinical signs of systemic toxicity were observed. At a 5% test item concentration, no signs of systemic toxicity were observed
- Ear thickness measurements:
At a 25% and 50% test item concentration, ear thickness increased more than 25% during the observation period from Day 1 pre-dose values. No ear thickness increase above 25% was observed at lower doses.
- Erythema scores: /
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: Determination of cellular proliferation (incorporated radioactivity), individual animal approach
- Criteria used to consider a positive response: erythema scores, Disintegrations Per Minute
TREATMENT PREPARATION AND ADMINISTRATION:
Test item dosing formulations (w/w) were homogenized to visually acceptable levels at appropriate concentrations to meet dose level requirements.
The dosing formulations were prepared daily and dosed within 4 hours after adding the vehicle to the test item.
The dosing formulations were kept at room temperature until dosing.
No adjustment was made for specific gravity of the vehicle and no correction was made for the purity/composition of the test item, since the test method requires a logical concentration range rather than specific dose levels.
The dorsal surface of both ears was topically treated (25 μL/ear) with the test item, at approximately the same time on each day (day 1-3). The concentrations were stirred with a magnetic stirrer immediately prior to dosing. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- The EC3 value (the estimated test item concentration that will give a SI =3) was determined, using linear interpolation.
Results and discussion
- Positive control results:
- The SI values calculated for the item concentrations 5, 10 and 25% were 1.1, 2.0 and 5.5 respectively. An EC3 value of 14.3% was calculated using linear interpolation.
The calculated EC3 value was found to be in the acceptable range of 4.8 and 19.5%. The results of the 6 monthly HCA reliability checks of the recent years were 13.4, 14.1, 17.3, 9.8, 17.8 and 19.2%.
Based on the results, it was concluded that the Local Lymph Node Assay as performed at Charles River Den Bosch is an appropriate model for testing for contact hypersensitivity.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Value:
- 2.2
- Variability:
- SE = 0.2
- Test group / Remarks:
- 1% test item
- Parameter:
- SI
- Value:
- 2.7
- Variability:
- SE = 0.4
- Test group / Remarks:
- 2% test item
- Parameter:
- SI
- Value:
- 3.2
- Variability:
- SE = 0.7
- Test group / Remarks:
- 5% test item
- Parameter:
- EC3
- Value:
- 3.8
- Remarks on result:
- other: determined through linear interpolation
- Cellular proliferation data / Observations:
- All auricular lymph nodes of the animals of the experimental and control groups were considered normal in size.
Any other information on results incl. tables
No erythema was observed in any of the animals.
Red test item remnants were present on the dorsal surface of the ears of several animals throughout the test item treated groups between Days 1 and 3, which did not hamper scoring of the skin reactions.
No mortality occurred and no clinical signs of systemic toxicity were observed in the animals. Body weights and body weight gains of experimental animals remained in the same range as controls over the study period.
Applicant's summary and conclusion
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- These results indicate that the test item could elicit a SI ≥ 3. The data showed a dose-response and an EC3 value (the estimated test item concentration that will give a SI =3) of 3.8% was calculated using linear interpolation. Based on these results:
• according to the recommendations made in the test guidelines (including all amendments), V134434 would be regarded as skin sensitizer.
• according to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) of the United Nations (2017) (including all amendments), V134434 should be classified as skin sensitizer (Category 1B).
• according to the Regulation (EC) No 1272/2008 on classification, labelling and packaging of items and mixtures (including all amendments), V134434 should be classified as skin sensitizer (Category 1B) and labeled as H317: May cause an allergic skin reaction. - Executive summary:
The objective of this study was to evaluate whether V134434 induces skin sensitization in mice after three epidermal exposures of the animals under the conditions described in this report.
The study was carried out based on the guidelines described in:
· OECD, Section 4, Health Effects, No.429 (2010),
· EC No 640/2012, Part B: "Skin Sensitization: Local Lymph Node Assay"
· EPA, OPPTS 870.2600 (2003) “Skin Sensitization”.
Test item concentrations selected for the main study were based on the results of a pre-screen test. At a 25% and 50% test item concentration, ear thickness increased more than 25% during the observation period from Day 1 pre-dose values and clinical signs of systemic toxicity wereobserved[KV1] . At a 10% test item concentration, clinical signs of systemic toxicity were also observed. Overall, these concentrations did not meet the selection criteria. At a 5% test item concentration, no signs of systemic toxicity were observed. The observed increase in ear thickness exceeding 25% was considered an incidental finding with no relevance since it was seen for one ear of one animal on Day 6 only and no relevant increase was seen at a higher concentration of 10%. Therefore the 5% concentration was selected as highest concentration for the main study.
In the main study, three experimental groups of five female CBA/J mice were treated with test item concentrations of 1, 2 or 5% w/w on three consecutive days, by open application on the ears. Five vehicle control animals were similarly treated, but with the vehicle alone (Acetone/Olive oil (4:1 v/v)). Three days after the last exposure, all animals were injected with3H-methyl thymidine and after five hours the draining (auricular) lymph nodes were excised and pooled for each animal. After precipitating the DNA of the lymph node cells, radioactivity measurements were performed. The activity was expressed as the number of disintegrations per minute (DPM) and a stimulation index (SI) was subsequently calculated for each group.
All auricular lymph nodes of the animals of the experimental and control groups were considered normal in size. No macroscopic abnormalities of the surrounding area were noted for any of the animals.
Mean DPM/animal values were 1040, 1285 and 1495 DPM for the experimental groups treated with test item concentrations 1, 2 and 5%, respectively. The mean DPM/animal value for the vehicle control group was 470 DPM. The SI values were 2.2, 2.7 and 3.2 for the test item concentrations 1, 2 and 5%, respectively.
These results indicate that the test item could elicit a SI ≥ 3. The data showed a dose-response and an EC3 value (the estimated test item concentration that will give a SI =3) of 3.8% was calculated.
The six-month reliability check with Alpha-hexylcinnamaldehyde indicates that the Local Lymph Node Assay as performed at Charles River Den Bosch is an appropriate model for testing for contact hypersensitivity.
Based on these results:
· according to the recommendations made in the test guidelines (including all amendments), V134434 would be regarded as skin sensitizer.
· according to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) of the United Nations (2017) (including all amendments), V134434 should be classified as skin sensitizer (Category 1B).
· according to the Regulation (EC) No 1272/2008 on classification, labelling and packaging of items and mixtures (including all amendments), V134434 should be classified as skin sensitizer (Category 1B) and labeled as H317: May cause an allergic skin reaction.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.